• to lower the chance of serious cardiovascular (heart and blood vessel) challenges in adults with form two diabetes and cardiovascular diseaseIn October 2024, Novo Nordisk revealed a analyze on scientific journal Nature a couple of novel glucose-delicate insulin NNC2215 which can minimize the risk of hypoglycemia in animal models.[67]To find out